PM 'remains committed' to Northern Powerhouse Rail

SES has announced the appointment of Joseph Cohen, co-founder of Trilantic Europe, to its board. This move is significant as it brings a wealth of experience and expertise to SES, particularly in investment and strategic growth. Cohen's background in private equity and his insights into the European market could help SES navigate its future challenges and opportunities, enhancing its position in the satellite communications industry.

India's recent proposal to ease investment rules could be a significant win for Amazon, potentially allowing the tech giant to expand its operations in the country. This move is expected to attract more foreign investment, boost the economy, and create jobs, making it a crucial development for both India and international businesses looking to enter the market.

Prosus-owned OLX is set to acquire La Centrale, a prominent French online marketplace, for €1.1 billion. This acquisition is significant as it strengthens OLX's position in the European market, allowing it to tap into the growing demand for online classifieds in France. By integrating La Centrale's established platform, OLX aims to enhance its service offerings and expand its user base, which could lead to increased revenue and market share.

A former board member of the Bank of Japan (BOJ) predicts that interest rates may rise to 1.5% under Governor Ueda's leadership. This potential hike is significant as it reflects the BOJ's response to ongoing economic challenges and inflationary pressures in Japan. A rate increase could signal a shift in monetary policy aimed at stabilizing the economy and managing inflation, which is crucial for both consumers and businesses.

In a surprising move, President Donald Trump has announced a 100% tariff on branded pharmaceutical products, alongside new levies on heavy trucks and kitchen cabinets. This decision raises concerns about the potential impact on healthcare costs and the economy, as such tariffs could lead to higher prices for consumers and strain relationships with trading partners. It's a significant shift in trade policy that could have far-reaching consequences.

Roche has indicated its plans for the U.S. market following President Trump's announcement regarding pharmaceutical tariffs. This development is significant as it highlights the ongoing discussions around drug pricing and trade policies, which could impact both the pharmaceutical industry and consumers in the U.S.